Efficacy and toxicity of peritumoral delivery of nanoconjugated cisplatin in an in vivo murine model of head and neck squamous cell carcinoma. [electronic resource]
- JAMA otolaryngology-- head & neck surgery Apr 2013
- 382-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
2168-619X
10.1001/jamaoto.2013.214 doi
Animals Antineoplastic Agents--administration & dosage Carcinoma, Squamous Cell--drug therapy Cisplatin--administration & dosage Dose-Response Relationship, Drug Drug Delivery Systems Female Head and Neck Neoplasms--drug therapy Maximum Tolerated Dose Mice Mice, Nude Neoplasms, Experimental Squamous Cell Carcinoma of Head and Neck Treatment Outcome Tumor Burden